(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMAMETRICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHARMAMETRICS

ST13

US500000079099860

Class

35, 44

Filing

79099860

Registration

4408972

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

73

Latest update

06/28/2025

Trademark type

Word

Nice classes

35, 44

Filing date

03/21/2011

Registration date

10/01/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/10/2024

Last transaction

06/28/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

01

Owner location

Freiburg, DE

Examiner

ESTRADA,LINDA M

Current location

Historical data usage

Holders and representatives

Holders

A. K. (pessoa física)
A. K. (pessoa física)

Representatives

Thomas J. Mango Cantor Colburn LLP

Technical classification

Nice Classes

Class 35Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business management consultancy

Class 44

Medical services in the nature of conducting medical and clinical examinations for the purpose of medical diagnosis

Publications

History of USPTO decisions and trademark events.

73 publications found

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

06/27/2025

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

05/27/2025

INPC

INVALIDATION PROCESSED

05/27/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/10/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/03/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/10/2024

71AG

REGISTERED-SEC.71 ACCEPTED

07/10/2024

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/18/2024

PR71

POST REGISTRATION ACTION MAILED - SEC.71

05/21/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/20/2024

ES71

TEAS SECTION 71 RECEIVED

09/22/2023

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

10/01/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

04/08/2021

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

05/21/2020

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

05/21/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

05/20/2020

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

11/20/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/01/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/01/2019

ES75

TEAS SECTION 71 & 15 RECEIVED

10/01/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/01/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/01/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/10/2014

FIMP

FINAL DISPOSITION PROCESSED

01/10/2014

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/01/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

10/01/2013

GPNX

NOTIFICATION PROCESSED BY IB

09/15/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/16/2013

PUBO

PUBLISHED FOR OPPOSITION

07/16/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/26/2013

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/26/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/26/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/12/2013

EXPT

EXPARTE APPEAL TERMINATED

06/10/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/10/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/08/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/08/2013

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

05/16/2013

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/08/2013

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/18/2013

GEA1

NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED

01/04/2013

GECD

ACTION DENYING REQ FOR RECON E-MAILED

01/04/2013

CNCF

ACTION CONTINUING FINAL - COMPLETED

01/04/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/02/2013

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/02/2013

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

12/12/2012

GEA1

NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED

10/08/2012

GECD

ACTION DENYING REQ FOR RECON E-MAILED

10/08/2012

CNCF

ACTION CONTINUING FINAL - COMPLETED

10/08/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/22/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/22/2012

ALIE

ASSIGNED TO LIE

09/12/2012

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/05/2012

EXPI

EX PARTE APPEAL-INSTITUTED

09/05/2012

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

09/05/2012

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

09/05/2012

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/05/2012

GNFR

FINAL REFUSAL E-MAILED

03/05/2012

CNFR

FINAL REFUSAL WRITTEN

03/05/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/07/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/06/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/06/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/27/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/27/2012

RFNT

REFUSAL PROCESSED BY IB

08/27/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/05/2011

RFRR

REFUSAL PROCESSED BY MPU

08/05/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/05/2011

CNRT

NON-FINAL ACTION WRITTEN

08/04/2011

MAFR

APPLICATION FILING RECEIPT MAILED

08/02/2011

DOCK

ASSIGNED TO EXAMINER

07/29/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/29/2011

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/28/2011

Continuous trademark protection

Get notified about every new filing that threatens PHARMAMETRICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.